The President & CEO of Cooper Co is Exercising Options

By Carrie Williams

Today, the President & CEO of Cooper Co, Robert S. Weiss, exercised options of Cooper Co for $8.91M.

Following Robert S. Weiss’ last COO Sell transaction on December 20, 2017, the stock climbed by 16.3%. In addition to Robert S. Weiss, one other COO executive reported Sell trades in the last month.

Based on Cooper Co’s latest earnings report for the quarter ending January 31, the company posted quarterly revenue of $590 million and GAAP net loss of $123 million. In comparison, last year the company earned revenue of $499 million and had a net profit of $75.8 million. The company has a one-year high of $260.26 and a one-year low of $192.75. COO’s market cap is $11.76B and the company has a P/E ratio of 67.97.

Based on 6 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $276.6, reflecting a -14.4% downside.

The insider sentiment on Cooper Co has been negative according to 54 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Robert S. Weiss’ trades have generated a 0.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Cooper Cos, Inc. operates as a medical device company. It operates through two business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers.